SCHEMBL124803

SCHEMBL124803

CCCC(F)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681900 0.84
SCHEMBL15851475 0.84
SCHEMBL29405962 0.84
SCHEMBL798836 0.80 TSHR (0.35)
SCHEMBL15851483 0.80
SCHEMBL6437670 0.80
SCHEMBL13826935 0.78 CES2 (0.43)
SCHEMBL799407 0.76 CES2 (0.46)
SCHEMBL799458 0.76 CES2 (0.46)
SCHEMBL13328745 0.76 CES2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569899-B1 SUBSTITUTED 3-ALKYL- AND 3-ARYLALKYL-1H-INDOL-1-YL-ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH CORP (US) 2006-06-28 EP claimed
JP-2006514640-A 2006-05-11 JP claimed
EP-1569899-A2 SUBSTITUTED 3-ALKYL AND 3-ARYLALKYL i 1H /i -INDOL-1-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) Wyeth (US) 2005-09-07 EP claimed
WO-2004052853-A2 SUBSTITUTED 3-ALKYL AND 3-ARYLALKYL 1H-INDOL-1-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) WYETH (US) 2004-06-24 WO claimed
US-20040116488-A1 Substituted 3-alkyl and 3-arylalkyl 1H-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) WYETH 2004-06-17 US claimed
US-5275669-A Degreasing glass, metal, plastic and fiber surfaces ALLIEDSIGNAL INC. (US) 1994-01-04 US claimed
WO-2024133913-A2 SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING HYOSCYAMINE NOVALIQ GMBH (DE) 2024-06-27 WO disclosed
US-12005033-B2 Compositions comprising mixtures of semifluorinated alkanes NOVALIQ GMBH (DE) 2024-06-11 US disclosed
WO-2024108095-A1 SEMIFLUORINATED ALKANE ANTIBIOTIC COMBINATION COMPOSITIONS FOR TREATMENT OF OCULAR DISORDERS COFFEY MARTIN (US) 2024-05-23 WO disclosed
US-11987623-B2 Stabilized antibody compositions NOVALIQ GMBH (DE) 2024-05-21 US disclosed
EP-4342537-A2 SEMIFLUORINATED ALKANE COMPOSITIONS Novaliq GmbH (DE) 2024-03-27 EP disclosed
EP-3100722-B1 SEMIFLUORINATED ALKANES FOR USE IN SOLUBILIZING MEIBUM NOVALIQ GMBH (DE) 2024-03-20 EP disclosed
US-11896559-B2 Opthalmic compositions comprising F6H8 NOVALIQ GMBH (DE) 2024-02-13 US disclosed
CN-1960958-A Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foams stabilizers GREAT LAKES CHEMICAL CORP (US) 2007-05-09 CN disclosed
CN-1957078-A Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foams stabilizers PCBU SERVICES INC (US) 2007-05-02 CN disclosed
CN-1938414-A Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film-forming foams, and foam stabilizers PCBU SERVICES INC (US) 2007-03-28 CN disclosed
US-20060106263-A1 Processes for production and purification of hydrofluoroolefins THE CHEMOURS COMPANY FC, LLC 2006-05-18 US disclosed
EP-1193309-B1 Solvent blend for use in high purity precursor removal AIR PROD & CHEM (US) 2004-11-03 EP disclosed
EP-1193309-A1 Solvent blend for use in high purity precursor removal AIR PRODUCTS AND CHEMICALS, INC. (US) 2002-04-03 EP disclosed
CN-1244859-A Benzenesulfonamide derivatives and drugs containing the same HOKURIKU SEIYAKA CO LTD (JP) 2000-02-16 CN disclosed